Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pharmacokinetics of 10 mg Teduglutide in Subjects With Renal Impairment Compared to Healthy Subjects With Normal Renal Function

This study has been completed.
Sponsor:
Collaborator:
NPS Pharma
Information provided by:
Nycomed
ClinicalTrials.gov Identifier:
NCT01028768
First received: December 3, 2009
Last updated: May 4, 2012
Last verified: April 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2010
  Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)